Wuxi Zhihexing Pharmaceutical Technology Co., Ltd. was invested and established in 2008, with annual sales exceeding 100 million yuan. It has introduced advanced biological information collection technology from the United States and has jointly built production and research with the National Academy of Medicine of the United States, the China Association for Science and Technology International Exchange, and the Chinese Academy of Chronic Disease Prevention and Control Research, gathering a strong professional technical team to jointly create an intelligent health management platform.
Zhihexing is one of the first batch of intelligent health demonstration enterprises in China, an innovative intelligent health management platform, a health cloud innovative application project, and a key supported enterprise. Under the national call to develop China's health industry, Zhihexing relies on advanced health management concepts, innovative development ideas, an excellent operations team, and a far-sighted industrial integration development model. It has successively established branches and representative offices in Wuxi, Nanjing, Shijiazhuang, Dezhou, Xi'an and other places, with a marketing network covering more than 20 provinces, municipalities and autonomous regions across the country, and more than 1,000 employees. It provides health management platform system solutions for the national basic public health field, serves the construction of grassroots basic public health, comprehensively and systematically solves data collection and information interconnection in the health management process, and realizes remote medical management as well as big data applications.
In addition, the Zhihexing intelligent health management platform has established strategic cooperative relations with more than ten large domestic and foreign institutions such as Yunnan Panlong Yunhai Group, Chengde Jingfukang Pharmaceutical, and the American Peptide Company, and has also established cooperation with authoritative media such as Guangdong Satellite TV, Yunnan Satellite TV, and Jilin Satellite TV. The company's developed new technological products such as the Aiyun remote intelligent blood pressure monitor and smart bracelets provide technologically leading and high-quality health electronic products to more than 50 million middle- and high-end families and individuals worldwide. At present, the company has received its first round of financing from a Hong Kong venture capital company and is expected to complete listing in 2019.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows